Form 4: Predictive Oncology Director Buys Shares

Sentiment:

Insider Transaction (Form 4)


Theodore Zhu, a Director of Predictive Oncology Inc., purchased 8,750 shares of common stock on September 8, 2026.

Summary

  • Open-market purchase: acquired 5,000 Common Stock at $10.88 ($54,375) on September 8, 2026; holds 16,314 after (Direct).
  • Open-market purchase: acquired 3,750 Common Stock at $11.72 ($43,950) on September 8, 2026; holds 16,314 after (Direct).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $98,325, committing personal capital to the stock.

Insider Transactions

Theodore Zhu — Director

DateTransactionSecuritySharesPriceValueHeld After
2026-09-08Open-market purchaseCommon Stock5,000$11$54.4K16,314
2026-09-08Open-market purchaseCommon Stock3,750$12$44.0K16,314

Key Dates

DateDescription
2026-09-08Open-market purchase (5,000 shares)
2026-09-08Open-market purchase (3,750 shares)

Keywords

insider transaction, Form 4, AGPU, Axe Compute Inc., bullish, Theodore Zhu

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.